

Real Chemistry
The strategic equation driving our 20% financial growth rate is the art of our integrated communication skills, plus our deep scientific and medical expertise, combined with our mastery of the science of data and technology. This year we doubled down on science in both our healthcare expertise and our dominance in AI.
We invested in growing a robust team of therapeutic experts, medical writers and PhD holders to challenge any competitor in the UK because healthcare expertise and deep scientific and medical intelligence is the very foundation of our communications work.
We also developed bespoke industry leading AI tools, ensuring that our approach is as data science and technology driven as the companies we serve. With 20+ AI solutions now offered across all facets of our business, data science and AI are the backbone supporting our insights, engagement, and results.
Our investment strategy was critical to achieving 39M (GBP) in revenue and winning 10 competitive pitches. And with 30% of the top 50 life science blockbuster brands on our roster and 25+ new drug approvals and expanded indications entrusted to us, we are committed to driving that strategy into the future.